Status:
COMPLETED
US Radiomics in Advanced Cervical Cancer
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Uterine Cervical Neoplasms
Locally Advanced Cervical Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This is a retrospective, multicenter observational study aimed at evaluating the role of ultrasound-based radiomics in patients with locally advanced cervical cancer (LACC). The study will analyze pre...
Eligibility Criteria
Inclusion
- Female patients aged ≥18 years
- Histologically confirmed diagnosis of locally advanced cervical cancer (FIGO 2018 stage IB3-IVA, excluding IIA1)
- Histologic subtypes: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
- Underwent transvaginal or transrectal ultrasound prior to treatment
- At least one pre-treatment DICOM ultrasound image of the primary tumor available
- Treated with either exclusive chemoradiotherapy or neoadjuvant chemoradiotherapy followed by radical surgery
- Completed at least 12 months of follow-up after primary treatment
- Signed informed consent (or equivalent declaration)
Exclusion
- Age \<18 years
- Only printed ultrasound images available
- Ultrasound images with poor tumor visualization or with text/markers obscuring the tumor
Key Trial Info
Start Date :
March 25 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 14 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06984289
Start Date
March 25 2025
End Date
May 14 2025
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy, 00168